Research at Karl Landsteiner University of Health Sciences offers new insight in brain connectivity and development. Krems (Austria), 20. November 2024. A recent study has uncovered the intricate ways in which a rare genetic mutation impacts brain cell communication, providing critical insights into the causes of a severe neurological disorder known as developmental and epileptic encephalopathy (DEE). […]
UpNano starts a new chapter in high precision two-photon polymerization (2PP) 3D printing with the launch of their NanoPro service. A newly developed printer model acts as the powerful engine that runs the new service, offering serial production of microparts with nanometer-resolution. Vienna, Austria 19. November 2024 – UpNano GmbH (Vienna, Austria) today unveiled the […]
Vienna, Austria – November 11th, 2024 – UpNano GmbH (Vienna, Austria), a leader in high-performance 2-photon polymerization (2PP) 3D printing solutions, has announced the release of the NanoOne green, a new addition to its acclaimed NanoOne series. Responding to increasing demand for enhanced transparent material versatility and higher resolution, the NanoOne green integrates a powerful 515 […]
UpNano receives capital boost for further advancing high-end 2PP 3D printers, materials, and services. Vienna, Austria 17. October 2024 – UpNano GmbH (Vienna, Austria) today announced the completion of its EUR 7M Series A round co-led by aws Gründungsfonds, Novacapital and IGO Innovation GmbH. The funds raised will allow UpNano to accelerate the development of […]
Research at Karl Landsteiner University of Health Sciences demonstrates synergistic effect of inhibiting two regulatory proteins in multiple myeloma. Krems (Austria), 16. October 2024: The simultaneous inhibition of the transcription factors Myc and JunB could represent a pioneering therapeutic option for the treatment of multiple myeloma (MM), the second most common type of blood cancer. […]
European study of sex-related differences in the type and treatment of heart valve diseases published, with physician from Karl Landsteiner University of Health Sciences as corresponding author. Krems (Austria), 25. September 2024: In Europe, incidences of severe native valvular heart disease (VHD) and their treatment vary between men and women. This is the key finding […]
IMC Krems participates in groundbreaking study that includes data from the third-party perspective of social media users Krems, Austria, 09. July 2024: Consumers using social media respond to interactions between micro-influencers and the hospitality industry when the latter two act in a “collaborative” setting (free food/accomodation vs. mentioning the hospitality business on social media). Interestingly, […]
Joint research by BOKU Tulln and IMC University of Applied Sciences Krems shows great potential in the recovery of valuable materials from electronic waste. Up to 85% recovery of rare earths achieved in the laboratory. Krems, Austria, 11. June 2024: A research collaboration between BOKU Tulln and IMC University of Applied Sciences Krems is using […]
he protein STAT3? has a positive influence on the course of acute myeloid leukaemia (AML) and could serve as a prognostic marker in the future. These are the outstanding results of a cancer research study at the Karl Landsteiner University of Health Sciences (KL Krems). In the work now published in Cell Death & Disease, an international research team succeeded in identifying the previously unknown effect of the protein on interferon-dependent signalling pathways.
AI identifies mutations. Karl Landsteiner University of Health Sciences once again sets standards with machine learning methods Krems (Austria), 16. May 2024: Machine learning (ML) methods can quickly and accurately diagnose mutations in gliomas – primary brain tumours. This is shown by a recent study by Karl Landsteiner University of Health Sciences (KL Krems). In […]